» Articles » PMID: 27121233

Assessing Trends in Palliative Surgery for Extrahepatic Biliary Malignancies: A 15-Year Multicenter Study

Abstract

Introduction: Extrahepatic biliary malignancies are often diagnosed at an advanced stage. We compared patients with unresectable perihilar cholangiocarcinoma (PHCC) and gallbladder cancer (GBC) who underwent a palliative procedure versus an aborted laparotomy.

Methods: Seven hundred seventy-seven patients who underwent surgery for PHCC or GBC between 2000 and 2014 were identified. Uni- and multivariable analyses were performed to identify factors associated with outcome.

Results: Utilization of preoperative imaging increased over time (CT use, 80.1 % pre-2009 vs. 90 % post-2009) (p < 0.001). The proportion of the patients undergoing curative-intent resection also increased (2000-2004, 67.0 % vs. 2005-2009, 74.5 % vs. 2010-2014, 78.8 %; p = 0.001). The planned surgery was aborted in 106 (13.7 %) patients and 94 (12.1 %) had a palliative procedure. A higher incidence of postoperative complications (19.2 vs. 3.8 %, p = 0.001) including deep surgical site infections (8.3 vs. 1.1 %), bleeding (4.8 vs. 0 %), bile leak (6.0 vs. 0 %) and longer length of stay (7 vs. 4.5 days) were observed among the patients who underwent a palliative surgical procedure versus an aborted non-therapeutic, non-palliative laparotomy (all p < 0.05). OS was comparable among the patients who underwent a palliative procedure (8.7 months) versus an aborted laparotomy (7.8 months) (p = 0.23).

Conclusion: Increased use of advanced imaging modalities was accompanied by increased curative-intent surgery. Compared with patients in whom surgery was aborted, patients who underwent surgical palliation demonstrated an increased incidence of postoperative morbidity with comparable survival.

Citing Articles

Early Palliative Care Following Aborted Cancer Surgery: Results of a Prospective Feasibility Trial.

Cloyd J, Khatri R, Sarna A, Stevens L, Heh V, Dillhoff M Ann Surg Open. 2024; 5(4):e520.

PMID: 39711683 PMC: 11661761. DOI: 10.1097/AS9.0000000000000520.


Surgeon Perspectives on the Management of Aborted Cancer Surgery: Results of a Society of Surgical Oncology Member Survey.

Lopez-Aguiar A, Sarna A, Wells-DiGregorio S, Huang E, Kneuertz P, Beane J Ann Surg Oncol. 2023; 31(4):2295-2302.

PMID: 38127216 DOI: 10.1245/s10434-023-14804-6.


Patient Experiences After Aborted Cancer Surgery: A Qualitative Study.

Stevens L, Wells-Di Gregorio S, Lopez-Aguiar A, Khatri R, Ejaz A, Pawlik T Ann Surg Oncol. 2023; 30(11):6844-6851.

PMID: 37540329 DOI: 10.1245/s10434-023-14046-6.


Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma.

Vugts J, Gaspersz M, Roos E, Franken L, Olthof P, Coelen R Ann Surg Oncol. 2020; 28(3):1483-1492.

PMID: 32901308 PMC: 7892510. DOI: 10.1245/s10434-020-09001-8.


[Intrahepatic cholangiocarcinoma : Results after 84 resections].

Neeff H, Holzner P, Menzel M, Bronsert P, Klock A, Lang S Chirurg. 2018; 89(5):374-380.

PMID: 29464308 DOI: 10.1007/s00104-018-0609-2.

References
1.
Valle J, Wasan H, Palmer D, Cunningham D, Anthoney A, Maraveyas A . Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010; 362(14):1273-81. DOI: 10.1056/NEJMoa0908721. View

2.
Connor S, Barron E, Redhead D, Ireland H, Madhavan K, Parks R . Palliation for suspected unresectable hilar cholangiocarcinoma. Eur J Surg Oncol. 2006; 33(3):341-5. DOI: 10.1016/j.ejso.2006.11.005. View

3.
Andersen J, Sorensen S, Kruse A, Rokkjaer M, Matzen P . Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut. 1989; 30(8):1132-5. PMC: 1434171. DOI: 10.1136/gut.30.8.1132. View

4.
Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P . Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg. 2009; 33(6):1247-54. DOI: 10.1007/s00268-009-9970-0. View

5.
Okusaka T, Nakachi K, Fukutomi A, Mizuno N, Ohkawa S, Funakoshi A . Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer. 2010; 103(4):469-74. PMC: 2939781. DOI: 10.1038/sj.bjc.6605779. View